| Ident. | Authors (with country if any) | Title |
|---|
| 000006 (2013) |
Kathryn N. Parkinson [Royaume-Uni] ; Heather O. Dickinson [Royaume-Uni] ; Catherine Arnaud [France] ; Alan Lyons [Irlande (pays)] ; Allan Colver [Royaume-Uni] ; Eva Beckung ; Jackie Parkes ; Jérôme Fauconnier ; Alan Lyons ; Susan Michelsen ; Marco Marcelli ; Catherine Arnaud ; Ute Thyen ; Marion Rapp | Pain in young people aged 13 to 17 years with cerebral palsy: cross-sectional, multicentre European study |
| 000010 (2013) |
Renato Puppi Munhoz [Brésil] ; Hélio A. Teive [Brésil] ; Hariklia Eleftherohorinou [Royaume-Uni] ; Lachlan J. Coin [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni, Brésil] | Demographic and motor features associated with the occurrence of neuropsychiatric and sleep complications of Parkinson's disease |
| 000011 (2013) |
Keyoumars Ashkan [Royaume-Uni] ; Paul Shotbolt [Royaume-Uni] ; Anthony S. David [Royaume-Uni] ; Michael Samuel [Royaume-Uni] | Deep brain stimulation: a return journey from psychiatry to neurology |
| 000012 (2013) |
Mojtaba Zarei [Royaume-Uni, Iran] ; Naroa Ibarretxe-Bilbao [Espagne] ; Yaroslau Compta [Espagne] ; Morgan Hough [Royaume-Uni] ; Carme Junque [Espagne] ; Nuria Bargallo [Espagne] ; Eduardo Tolosa [Espagne] ; Maria Jose Martí [Espagne] | Cortical thinning is associated with disease stages and dementia in Parkinson's disease |
| 000016 (2013) |
D C Consonni [Italie] ; Straif [France] ; Symons [États-Unis] ; Tomenson [Royaume-Uni] ; Amelsvoort Van [Pays-Bas] ; Sleeuwenhoek [Royaume-Uni] ; Cherrie [Royaume-Uni] ; Bonetti [Italie] ; Colombo [Italie] ; Farrar [Royaume-Uni] ; Carugno [Italie] ; Bertazzi [Italie] | 284 Cancer risk among tetrafluoroethylene (TFE) synthesis and polymerisation workers |
| 000022 (2012) |
Pv Dissanayake [Royaume-Uni] ; R. Wasala [Royaume-Uni] | Wolff-parkinson-white syndrome diagnosed following binge drinking associated arrhythmia |
| 000029 (2012) |
Claire L. Tomlinson [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Charmaine Meek [Royaume-Uni] ; Clare P. Herd [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Rebecca Stowe [Royaume-Uni] ; Laila Shah [Royaume-Uni] ; Catherine Sackley [Royaume-Uni] ; Katherine H O. Deane [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Natalie Ives [Royaume-Uni] | Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis |
| 000039 (2012) |
Andreas R. Kupsch [Allemagne] ; Nin Bajaj [Royaume-Uni] ; Frederick Weiland [États-Unis] ; Antonio Tartaglione [Italie] ; Susanne Klutmann [Allemagne] ; Melanie Buitendyk [Canada] ; Paul Sherwin [États-Unis] ; Ann Tate [États-Unis] ; Igor D. Grachev [États-Unis] | Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study |
| 000046 (2012) |
Matthew B. Davidson [Royaume-Uni] ; David J M. Mcghee [Royaume-Uni] ; Carl E. Counsell [Royaume-Uni] | Comparison of patient rated treatment response with measured improvement in Parkinson's disease |
| 000048 (2012) |
Manu Sharma ; John P A. Ioannidis [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Alexis Brice [France] ; Lars Bertram [Allemagne] ; Maria Bozi [Grèce] ; Maria Barcikowska [Pologne] ; David Crosiers [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Maurizio F. Facheris ; Matthew Farrer [Canada] ; Gaetan Garraux ; Suzana Gispert [Allemagne] ; Georg Auburger ; Carles Vilari O-Güell [Canada] ; Georgios M. Hadjigeorgiou [Grèce] ; Andrew A. Hicks ; Nobutaka Hattori [Japon] ; Beom S. Jeon [Corée du Sud] ; Zygmunt Jamrozik [Pologne] ; Anna Krygowska-Wajs [Pologne] ; Suzanne Lesage [France] ; Christina M. Lill [Grèce, Allemagne] ; Juei-Jueng Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Peter Lichtner [Allemagne] ; Anthony E. Lang [Canada] ; Cecile Libioulle [Canada] ; Miho Murata [Japon] ; Vincent Mok [Hong Kong] ; Barbara Jasinska-Myga [Pologne] ; George D. Mellick [Australie] ; Karen E. Morrison [Royaume-Uni] ; Thomas Meitnger [Allemagne] ; Alexander Zimprich [Autriche] ; Grzegorz Opala [Allemagne] ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park [Allemagne] ; Aldo Quattrone [Italie] ; Ekaterina Rogaeva [Canada] ; Owen A. Ross [États-Unis] ; Leonidas Stefanis [Grèce] ; Joanne D. Stockton [Royaume-Uni] ; Wataru Satake [Japon] ; Peter A. Silburn [Australie] ; Tim M. Strom [Allemagne, Canada] ; Jessie Theuns [Belgique] ; Eng- King Tan [Singapour] ; Tatsushi Toda [Japon] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Christine Van Broeckhoven [Belgique] ; Karin Wirdefeldt ; Zbigniew Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Harumi S. Yomono [Japon] ; Kuo-Chu Yueh [Taïwan] ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore [États-Unis] ; Rejko Krüger | A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants |
| 000050 (2012) |
Jose Bras [Royaume-Uni] ; Rita Guerreiro [Royaume-Uni] ; John Hardy [Royaume-Uni] | Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease |
| 000057 (2012) |
Steve Arnold [Royaume-Uni] ; Georgios Pampalakis [Grèce] ; Kalliopi Kantiotou [Grèce] ; Dilson Silva [Brésil] ; Celia Cortez [Brésil] ; Sotiris Missailidis [Royaume-Uni] ; Georgia Sotiropoulou [Grèce] | One round of SELEX for the generation of DNA aptamers directed against KLK6 |
| 000061 (2012) |
Chong Gao [République populaire de Chine] ; Christian Hölscher [Royaume-Uni] ; Yueze Liu [République populaire de Chine] ; Lin Li [République populaire de Chine] | GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease |
| 000062 (2012) |
Anne Corbett [Royaume-Uni] ; James Pickett [Royaume-Uni] ; Alistair Burns [Royaume-Uni] ; Jonathan Corcoran [Royaume-Uni] ; Stephen B. Dunnett [Royaume-Uni] ; Paul Edison [Royaume-Uni] ; Jim J. Hagan [Royaume-Uni] ; Clive Holmes [Royaume-Uni] ; Emma Jones [Royaume-Uni] ; Cornelius Katona [Royaume-Uni] ; Ian Kearns [Royaume-Uni] ; Patrick Kehoe [Royaume-Uni] ; Amrit Mudher [Royaume-Uni] ; Anthony Passmore [Royaume-Uni] ; Nicola Shepherd [Royaume-Uni] ; Frank Walsh [Royaume-Uni] ; Clive Ballard [Royaume-Uni] | Drug repositioning for Alzheimer's disease |
| 000067 (2011) |
Zhijun Yao [République populaire de Chine] ; Bin Hu [République populaire de Chine, Royaume-Uni] ; Lina Zhao [République populaire de Chine] ; Chuanjiang Liang [République populaire de Chine] | Analysis of Gray Matter in AD Patients and MCI Subjects Based Voxel-Based Morphometry |
| 000071 (2011) |
Jonathan R. Evans [Royaume-Uni] ; Sarah L. Mason [Royaume-Uni] ; Caroline H. Williams-Gray [Royaume-Uni] ; Thomas Foltynie [Royaume-Uni] ; Carol Brayne [Royaume-Uni] ; Trevor W. Robbins [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | The natural history of treated Parkinson's disease in an incident, community based cohort |
| 000076 (2011) |
T. Foltynie [Royaume-Uni] ; L. Zrinzo [Royaume-Uni] ; I. Martinez-Torres [Espagne] ; E. Tripoliti [Royaume-Uni] ; E. Petersen [États-Unis] ; E. Holl [Royaume-Uni, Autriche] ; I. Aviles-Olmos [Royaume-Uni] ; M. Jahanshahi [Royaume-Uni] ; M. Hariz [Royaume-Uni, Suède] ; P. Limousin [Royaume-Uni] | MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety |
| 000087 (2011) |
Hayriye Cagnan [Royaume-Uni] ; Kevin Dolan [Pays-Bas] ; Xuan He [Pays-Bas] ; Maria Fiorella Contarino [Pays-Bas] ; Richard Schuurman [Pays-Bas] ; Pepijn Van Den Munckhof [Pays-Bas] ; Wytse J. Wadman [Pays-Bas] ; Lo Bour [Pays-Bas] ; Hubert C F. Martens [Pays-Bas] | Automatic subthalamic nucleus detection from microelectrode recordings based on noise level and neuronal activity |
| 000088 (2011) |
Christopher Wren [Royaume-Uni] ; Melanie Vogel [Allemagne] ; Stephen Lord [Royaume-Uni] ; Dominic Abrams [Royaume-Uni] ; John Bourke [Royaume-Uni] ; Philip Rees [Royaume-Uni] ; Eric Rosenthal [Royaume-Uni] | Accuracy of algorithms to predict accessory pathway location in children with Wolff–Parkinson–White syndrome |
| 000090 (2011) |
Yan Rolland [France] ; Marc Vérin [France] ; Christine A. Payan [France] ; Simon Duchesne [Canada] ; Eduard Kraft [Allemagne] ; Till K. Hauser [Allemagne] ; Josef Jarosz [Royaume-Uni] ; Neil Deasy [Royaume-Uni] ; Luc Defevbre [France] ; Christine Delmaire [France] ; Didier Dormont [France] ; Albert C. Ludolph [Allemagne] ; Gilbert Bensimon [France] ; P Nigel Leigh [Royaume-Uni, France] | A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability |
| 000093 (2011) |
Mari Carmen Portillo [Royaume-Uni] ; Sarah Cowley [Royaume-Uni] | Working the way up in neurological rehabilitation: the holistic approach of nursing care |
| 000095 (2011) |
Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ray K. Chaudhuri [Royaume-Uni] ; Marcelo Merello [Argentine] ; Robert Hauser [États-Unis] ; Regina Katzenschlager [Autriche] ; Per Odin [Allemagne] ; Mark Stacy [États-Unis] ; Fabrizio Stocchi [Italie] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Wearing‐off scales in Parkinson's disease: Critique and recommendations |
| 000096 (2011) |
Neil K. Archibald [Royaume-Uni] ; Mike P. Clarke [Royaume-Uni] ; Urs P. Mosimann [Royaume-Uni, Suisse] ; David J. Burn [Royaume-Uni] | Visual symptoms in Parkinson's disease and Parkinson's disease dementia |
| 000106 (2011) |
Andrew King ; Satomi Maekawa ; Istvan Bodi ; Claire Troakes [Royaume-Uni] ; Safa Al-Sarraj | Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP‐43 proteinopathies but are only rarely additionally immunopositive for phosphorylation‐dependent TDP‐43 |
| 000109 (2011) |
Elina Tripoliti [Royaume-Uni] ; Laura Strong [Royaume-Uni] ; Freya Hickey [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Joseph Candelario [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] | Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease |
| 000112 (2011) |
Gabriella Constantinescu [Australie] ; Deborah Theodoros [Australie] ; Trevor Russell [Australie] ; Elizabeth Ward [Australie] ; Stephen Wilson [Australie] ; Richard Wootton [Royaume-Uni] | Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non‐inferiority trial |
| 000120 (2011) |
Ashley H. Spencer [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] ; Alfonso Fasano [Italie] ; Andrea E. Cavanna [Royaume-Uni] | The prevalence and clinical characteristics of punding in Parkinson's disease |
| 000125 (2011) |
Alison Yarnall [Royaume-Uni] ; Lynn Rochester [Royaume-Uni] ; David J. Burn [Royaume-Uni] | The interplay of cholinergic function, attention, and falls in Parkinson's disease |
| 000126 (2011) |
Pablo Martinez-Martin [Espagne] ; Carmen Rodriguez-Blazquez [Espagne] ; Monica M. Kurtis [Espagne] ; K. Ray Chaudhuri [Royaume-Uni] | The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease |
| 000135 (2011) |
Anne Pavy-Le Traon [France] ; Gerard Amarenco [France] ; Susanne Duerr [Autriche] ; Horacio Kaufmann [États-Unis] ; Heinz Lahrmann [Autriche] ; Stephanie R. Shaftman [États-Unis] ; François Tison [France] ; Gregor K. Wenning [Autriche] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Olivier Rascol [France] | The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension |
| 000141 (2011) |
Lynn Rochester [Royaume-Uni] ; Katherine Baker [Royaume-Uni] ; Alice Nieuwboer [Belgique] ; David Burn [Royaume-Uni] | Targeting dopa‐sensitive and dopa‐resistant gait dysfunction in Parkinson's disease: Selective responses to internal and external cues |
| 000144 (2011) |
Nick Miller [Royaume-Uni] ; Emma Noble [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; Katherine H. O. Deane [Royaume-Uni] ; Catherine Gibb [Royaume-Uni] | Survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: patients' and carers' perspectives |
| 000155 (2011) |
Carl E. Clarke [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops? |
| 000164 (2011) |
Claudia Trenkwalder [Allemagne] ; Bryan Kies [Afrique du Sud] ; Monika Rudzinska [Pologne] ; Jennifer Fine [Afrique du Sud] ; Janos Nikl [Hongrie] ; Krystyna Honczarenko [Pologne] ; Peter Dioszeghy [Hongrie] ; Dennis Hill [États-Unis] ; Tim Anderson [Nouvelle-Zélande] ; Vilho Myllyla [Finlande] ; Jan Kassubek [Allemagne] ; Malcolm Steiger [Royaume-Uni] ; Marco Zucconi [Italie] ; Eduardo Tolosa [Espagne] ; Werner Poewe [Autriche] ; Erwin Surmann [Allemagne] ; John Whitesides [États-Unis] ; Babak Boroojerdi [Allemagne] ; Kallol Ray Chaudhuri [Royaume-Uni] ; the RECOVER Study Group | Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER) |
| 000177 (2011) |
M. Duleeka W. Knipe [Royaume-Uni] ; Mirdhu M. Wickremaratchi [Royaume-Uni] ; Emma Wyatt-Haines [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] | Quality of life in young‐ compared with late‐onset Parkinson's disease |
| 000184 (2011) |
Wassilios G. Meissner [France] ; Mark Frasier [États-Unis] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Andres Lozano [Canada] ; Paola Piccini [Royaume-Uni] ; José A. Obeso [Espagne] ; Olivier Rascol [France] ; Anthony Schapira [Royaume-Uni] ; Valerie Voon [Royaume-Uni] ; David M. Weiner [États-Unis] ; François Tison [France] ; Erwan Bezard [France] | Priorities in Parkinson's disease research |
| 000193 (2011) |
Andrew Chan [Allemagne, Espagne] ; Munir Pirmohamed [Royaume-Uni] ; Manuel Comabella [Espagne] | Pharmacogenomics in neurology: Current state and future steps |
| 000197 (2011) |
Atbin Djamshidian [Royaume-Uni] ; Francisco Cardoso [Brésil] ; Donald Grosset [Royaume-Uni] ; Henrietta Bowden-Jones [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Pathological gambling in Parkinson's disease—a review of the literature |
| 000199 (2011) |
Hans-Gert Bernstein ; Mary Johnson ; Robert H. Perry ; Fiona E. N. Lebeau [Royaume-Uni] ; Henrik Dobrowolny ; Bernhard Bogerts ; Elaine K. Perry | Partial loss of parvalbumin‐containing hippocampal interneurons in dementia with Lewy bodies |
| 000202 (2011) |
Daniel Weintraub [États-Unis] ; David J. Burn [Royaume-Uni] | Parkinson's disease: The quintessential neuropsychiatric disorder |
| 000206 (2011) |
Claudia Trenkwalder [Allemagne] ; Ralf Kohnen [États-Unis, Allemagne] ; Birgit Högl [Autriche] ; Vinod Metta [Royaume-Uni] ; Friederike Sixel-Döring [Allemagne] ; Birgit Frauscher [Autriche] ; Julia Hülsmann [États-Unis, Allemagne] ; Pablo Martinez-Martin [Espagne] ; Kallol Ray Chaudhuri [Royaume-Uni] | Parkinson's disease sleep scale—validation of the revised version PDSS‐2 |
| 000207 (2011) |
Michael J. Devine [Royaume-Uni] ; Katrina Gwinn [États-Unis] ; Andrew Singleton [États-Unis] ; John Hardy [Royaume-Uni] | Parkinson's disease and α‐synuclein expression |
| 000213 (2011) |
Fabrizio Stocchi [Italie] ; Luigi Giorgi [Royaume-Uni] ; Brian Hunter [Royaume-Uni] ; Anthony Hv Schapira [Royaume-Uni] | PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease |
| 000215 (2011) |
Harriet Quigley [Royaume-Uni] ; Sean J. Colloby [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] | PET imaging of brain amyloid in dementia: a review |
| 000232 (2011) |
Nick Miller [Royaume-Uni] ; Katherine H. O. Deane [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; Emma Noble [Royaume-Uni] ; Catherine Gibb [Royaume-Uni] | National survey of speech and language therapy provision for people with Parkinson's disease in the United Kingdom: therapists’ practices |
| 000235 (2011) |
Peter Arthur-Farraj [Royaume-Uni] ; Katharina Wanek [Royaume-Uni] ; Janina Hantke [Royaume-Uni] ; Catherine M. Davis [États-Unis] ; Anuj Jayakar ; David B. Parkinson [Royaume-Uni] ; Rhona Mirsky [Royaume-Uni] ; Kristján R. Jessen [Royaume-Uni] | Mouse schwann cells need both NRG1 and cyclic AMP to myelinate |
| 000242 (2011) |
Julius Huebl [Allemagne] ; Thomas Schoenecker [Allemagne] ; Sandy Siegert [Allemagne] ; Christof Brücke [Allemagne] ; Gerd-Helge Schneider [Allemagne] ; Andreas Kupsch [Allemagne] ; Kielan Yarrow [Royaume-Uni] ; Andrea A. Kühn [Allemagne] | Modulation of subthalamic alpha activity to emotional stimuli correlates with depressive symptoms in Parkinson's disease |
| 000247 (2011) |
A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis] | Milestones in neuroimaging |
| 000249 (2011) |
Daniela Berg [Allemagne] ; Jonathan D. Steinberger [États-Unis] ; C. Warren Olanow [États-Unis] ; Thomas P. Naidich [États-Unis] ; Tarek A. Yousry [Royaume-Uni] | Milestones in magnetic resonance imaging and transcranial sonography of movement disorders |
| 000251 (2011) |
Mark Hallett [États-Unis, Royaume-Uni] ; John Rothwell [Royaume-Uni] | Milestones in clinical neurophysiology |
| 000253 (2011) |
Glenda Halliday [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Matthew Stern [États-Unis] | Milestones in Parkinson's disease—Clinical and pathologic features |
